{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T10:23:44Z","timestamp":1756463024776,"version":"3.44.0"},"reference-count":36,"publisher":"BMJ","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["DTB"],"published-print":{"date-parts":[[2005,4]]},"abstract":"<jats:p>Bipolar disorder is a severe, chronic mental illness characterised by repeated episodes of mania or hypomania, depression or mixed affective states.1 Depending on the clinical context, treatment may involve drugs, psychological therapies, social interventions and\/or electroconvulsive therapy (ECT).2<jats:sup>,<\/jats:sup>3 Here we concentrate on the role of drug treatments for acute manic or depressive episodes in adults with bipolar disorder. A second article will consider their role as maintenance and preventive therapy, and in special situations such as pregnancy.<\/jats:p>","DOI":"10.1136\/dtb.2005.43428","type":"journal-article","created":{"date-parts":[[2008,7,18]],"date-time":"2008-07-18T16:15:40Z","timestamp":1216397740000},"page":"28-32","source":"Crossref","is-referenced-by-count":4,"title":["Drug treatments for bipolar disorder: 1 - Acute manic or depressive"],"prefix":"10.1136","volume":"43","member":"239","published-online":{"date-parts":[[2005,4,1]]},"reference":[{"key":"2025082723210821000_43.4.28.1","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1016\/S0924-977X(03)00076-2","article-title":"Issues in the treatment of bipolar disorder","volume":"13","author":"Kasper","year":"2003","journal-title":"Eur Neuropsychopharmacology"},{"key":"2025082723210821000_43.4.28.2","first-page":"1","article-title":"Practice guideline for the treatment of patients with bipolar disorder (revision)","volume":"159","author":"American Psychiatric Association","year":"2002","journal-title":"Am J Psychiatry"},{"key":"2025082723210821000_43.4.28.3","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.159.1.1"},{"key":"2025082723210821000_43.4.28.4","unstructured":"American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders Fourth Edition (DSM-IV) Washington, DC: American Psychiatric Association 1994."},{"key":"2025082723210821000_43.4.28.5","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1001\/archpsyc.59.6.530","article-title":"The long-term natural history of the weekly symptomatic status of bipolar I disorder","volume":"59","author":"Judd","year":"2002","journal-title":"Arch Gen Psychiatry"},{"key":"2025082723210821000_43.4.28.6","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.59.6.530"},{"key":"2025082723210821000_43.4.28.7","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-0327(00)00203-2"},{"key":"2025082723210821000_43.4.28.8","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ps.52.1.51"},{"key":"2025082723210821000_43.4.28.9","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.186.1.32"},{"key":"2025082723210821000_43.4.28.10","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1994.03510360044034"},{"key":"2025082723210821000_43.4.28.11","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v66n0116"},{"key":"2025082723210821000_43.4.28.12","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2710.2000.00278.x"},{"key":"2025082723210821000_43.4.28.13","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1192\/pb.27.12.446","article-title":"Sodium valproate or valproate semisodium: is there a difference in the treatment of bipolar disorder?","volume":"27","author":"Fisher","year":"2003","journal-title":"Psychiatr Bull"},{"key":"2025082723210821000_43.4.28.14","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004052"},{"key":"2025082723210821000_43.4.28.15","doi-asserted-by":"crossref","first-page":"478","DOI":"10.4088\/JCP.v65n0405","article-title":"A multicenter, randomized, double-blind, placebo-controlled trial of extended-release carbamazepine capsules as monotherapy for bipolar disorder patients with manic or mixed episodes","volume":"65","author":"Weisler","year":"2004","journal-title":"J Clin Psychiatry"},{"key":"2025082723210821000_43.4.28.16","first-page":"74","article-title":"Anticonvulsants and antipsychotics in the treatment of bipolar disorder","volume":"59","author":"Keck","year":"1998","journal-title":"J Clin Psychiatry"},{"key":"2025082723210821000_43.4.28.17","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s002130000380","article-title":"Carbamazepine and valproate monotherapy: feasibility, relative safety and efficacy, and therapeutic drug monitoring in manic disorder","volume":"150","author":"Vasudev","year":"2000","journal-title":"Psychopharmacology"},{"key":"2025082723210821000_43.4.28.18","doi-asserted-by":"publisher","DOI":"10.1007\/s002130000380"},{"key":"2025082723210821000_43.4.28.19","doi-asserted-by":"publisher","DOI":"10.1023\/A:1009066725103"},{"key":"2025082723210821000_43.4.28.20","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-200012000-00004"},{"key":"2025082723210821000_43.4.28.21","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004040"},{"key":"2025082723210821000_43.4.28.22","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1176\/appi.ajp.161.6.1057","article-title":"Rapid antimanic effect of risperidone monotherapy: a 3-week multicenter, double-blind, placebo-controlled trial","volume":"161","author":"Hirschfeld","year":"2004","journal-title":"Am J Psychiatry"},{"key":"2025082723210821000_43.4.28.23","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.161.6.1057"},{"key":"2025082723210821000_43.4.28.24","unstructured":"Marcus R . 2003 Aripiprazole versus placebo in acute mania [online]. Available: http:\/\/www.wpic.pitt.edu\/STANLEY\/5thbipconf\/Abstracts\/posters6.htm#127 [Accessed 15 March 2005]."},{"key":"2025082723210821000_43.4.28.25","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1176\/appi.ajp.160.4.741","article-title":"Ziprasidone in the treatment of acute bipolar mania: a three-week, placebo-controlled, double-blind, randomized trial","volume":"160","author":"Keck","year":"2003","journal-title":"Am J Psychiatry"},{"key":"2025082723210821000_43.4.28.26","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.160.4.741"},{"key":"2025082723210821000_43.4.28.27","unstructured":"National Institute for Clinical Excellence. 2003 Olanzapine and valproate semisodium in the treatment of acute mania associated with bipolar I disorder [online]. Available: http:\/\/www.nice.org.uk\/pdf\/66_bipolardisorder_fullguidance.pdf [Accessed 15 March 2005]."},{"key":"2025082723210821000_43.4.28.28","doi-asserted-by":"crossref","first-page":"596","DOI":"10.2337\/diacare.27.2.596","article-title":"Consensus development conference on antipsychotic drugs and obesity and diabetes","volume":"27","author":"American Diabetes Association","year":"2004","journal-title":"Diabetes Care"},{"key":"2025082723210821000_43.4.28.29","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.27.2.596"},{"key":"2025082723210821000_43.4.28.30","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1192\/bjp.164.4.549","article-title":"Induction of mania with selective serotonin re-uptake inhibitors and tricyclic antidepressants","volume":"164","author":"Peet","year":"1994","journal-title":"Br J Psychiatry"},{"key":"2025082723210821000_43.4.28.31","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.164.4.549"},{"key":"2025082723210821000_43.4.28.32","doi-asserted-by":"publisher","DOI":"10.1016\/S0193-953X(05)70285-9"},{"key":"2025082723210821000_43.4.28.33","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.161.9.1537"},{"key":"2025082723210821000_43.4.28.34","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-0327(01)00449-9"},{"key":"2025082723210821000_43.4.28.35","doi-asserted-by":"crossref","first-page":"79","DOI":"10.4088\/JCP.v60n0203","article-title":"A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression","volume":"60","author":"Calabrese","year":"1999","journal-title":"J Clin Psychiatry"},{"key":"2025082723210821000_43.4.28.36","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v60n0203"}],"container-title":["Drug and Therapeutics Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/dtb.2005.43428","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T06:21:14Z","timestamp":1756362074000},"score":1,"resource":{"primary":{"URL":"https:\/\/dtb.bmj.com\/lookup\/doi\/10.1136\/dtb.2005.43428"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,4]]},"references-count":36,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2005,4,1]]},"published-print":{"date-parts":[[2005,4]]}},"alternative-id":["10.1136\/dtb.2005.43428"],"URL":"https:\/\/doi.org\/10.1136\/dtb.2005.43428","relation":{},"ISSN":["0012-6543","1755-5248"],"issn-type":[{"type":"print","value":"0012-6543"},{"type":"electronic","value":"1755-5248"}],"subject":[],"published":{"date-parts":[[2005,4]]}}}